[Form 4] Sight Sciences, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Sight Sciences, Inc. (SGHT) reported that Matthew Link, its Chief Commercial Officer, resigned effective 08/31/2025. The filing states that because of the resignation the reporting person is no longer subject to Section 16 obligations and will not file further Forms 4 or 5 for transactions in the issuer's equity. The Form 4 was signed by an attorney-in-fact on 09/03/2025.

Positive

• Resignation disclosed promptly with an effective date of 08/31/2025
• Reporting obligations clarified: the filer states he is no longer subject to Section 16 and will not file further Forms 4/5

Negative

• Executive departure of the Chief Commercial Officer on 08/31/2025, a potentially material leadership change
• No successor named in this filing, leaving uncertainty about commercial leadership continuity

Insights

Corporate Governance Expert

CCO departure ends insider reporting obligations; watch management continuity.

The resignation of the Chief Commercial Officer on 08/31/2025 reduces the company's roster of executive officers and removes Section 16 reporting requirements for that individual. This is an operational change rather than a transaction-driven disclosure.

Continuity risks depend on whether duties were reassigned or replaced; monitor subsequent filings or announcements for a named successor in the near term.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Link Matthew

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Effective August 31, 2025, the Reporting Person resigned from his role as Chief Commercial Officer of the Issuer. As a result, the Reporting Person is no longer subject to Section 16 in connection with his transactions in the equity securities of the Issuer and therefore will no longer report any such transactions on Form 4 or Form 5.

	/s/ Jeremy Hayden, Attorney-in-Fact for Matthew Link	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Sight Sciences (SGHT) disclose in the Form 4?

The filing states that Matthew Link resigned as Chief Commercial Officer effective 08/31/2025 and is no longer subject to Section 16 reporting for the issuer's equity.

Will Matthew Link file future Forms 4 or 5 for SGHT?

No. The filing explicitly says the Reporting Person "will no longer report any such transactions on Form 4 or Form 5" after his resignation.

When was the Form 4 signed?

The Form 4 was signed by an attorney-in-fact on 09/03/2025.

Does the Form 4 show any equity transactions?

No transaction lines or amounts are shown in the provided Form 4; the disclosure relates solely to the resignation and reporting status.

Does this filing disclose reasons for the resignation?

No. The filing contains only the effective resignation date and the resulting change in Section 16 reporting status.